Invest with One of the Largest Privately Held Real Estate Companies in the U.S. 100% USCIS Approval Trusted Worldwide by Over 1,000 Families Talk to An Expert Today $6.5 Billion Real Estate Portfolio A+ and A1 Credit Ratings from S&P and Moody's Over $530 Million EB-5 Raised 30+ Years Investment Track Record The Foundry is the premier medical device company incubator and a preferred partner to LSV. No work/life balance. ZELTIQ is a medical device company developing and marketing a non-invasive, office-based procedure that uses Cryolipolysis, a proprietary cooling technology, to eliminate fat. Please only use it for a guidance and The Lightstone Group's actual income may vary a lot from the dollar amount shown above. Its lead program was acquired by Gilead Sciences (NASDAQ: GILD) in 2016. [42] Lichtenstein also has a weekly radio show which covers the Jewish perspective on a different controversial topic each week. Lightstone has invested directly in individual real estate assets and in real estate operating companies. Sector: Biopharmaceuticals, Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University B.S. Disarm Therapeutics is a biotechnology company that is creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease-causing disability and disease progression. Prior to joining Proteolix, Dr. Molineaux was Vice President of Biology at Rigel Pharmaceuticals from 2000 to 2003. She brings experience in creating, launching, building and operating early stage biotechnology companies including Magenta Therapeutics (NASDAQ:MGTA) and Decibel Therapeutics (NASDAQ:DBTX). Lightstone Group Completes $2.3 Billion Disposition of Prime Outlets Client News The $2.3 billion deal freed up cash for further investments. Since its inception in 1998, Hanson has led The Foundry in all of its activities. Brendan is a Vice President at Lightstone Ventures evaluating opportunities in the biopharmaceutical sector. Get insight into Lightstone Group! Prior to Momenta, Young was a business development professional at Biogen, driving a variety of transactions. Weve built our reputation on our ability to identify opportunities early, analyze their potential, and transform them into above-market investments. Real estate portfolio. He previously served on the boards of nine companies that were acquired Claret Medical, Miramar Labs, Twelve Medical, Ardian, Access Closure, Acclarent, Cabochon, EPI and TransVascular. Lichtenstein in 2003 acquired Prime Retail for $638 million, seen as one of the largest retail purchases in United States at the time. in Biology from St. Josephs University, Ph.D. in Molecular and Cell Biology from the Institute on Fundamental Biology, Barcelona, Ph.D. in Molecular and Cell Biology from University of California, Berkeley, Ph.D. in Molecular Biology from University of a Southern California (212) 616-9969. The company has utilized its proprietary discovery platform to develop a portfolio of competitively differentiated therapeutic programs. Jason was also previously a co-founder and on the Board of Tarsus Medical before its acquisition by Integra Life Sciences in 2013. We are focused on several disease areas including the central nervous system (CNS), immunology with particular interest in autoimmune diseases, next-generation approaches in oncology and ophthalmology. Lightstone Group & Affiliates Careers and Employment About the company Founded 2004 Company size 201 to 500 Revenue $500M to $1B (USD) Industry Real Estate Headquarters 460 Park Avenue, New York. [32], Lightstone continues to seek new acquisitions across the United States in both urban and suburban locations and across a wide range of property types, including industrial, office, retail, multifamily and hospitality. In 2007, The Lightstone Group acquired Extended Stay Hotels for $8.1 billion and sold Prime Retail in 2010 for $2.1 billion, earning a large profit from the sale of the outlet mall group. 8/7/2022 6:02 AM. Lightstone has finalized a deal to buy a portfolio of 27 multifamily assets in suburban Detroit for $1 billion from Hartman & Tyner, the company announced. David Lichtenstein is Chairman and CEO of Lightstone, which he founded in 1988. $1 Million - $5 Million. in Mechanical Engineering from Cornell University, Ph.D. Neuroscience from Tufts University School of Medicine, Graduate School of Biomedical Sciences, B.S. Brendan was previously a life sciences strategy consultant at L.E.K. Willow is a medical device company commercializing a wearable breast pump that allows women to achieve their breastfeeding goals without pressing pause on their own lives. Scioderm is a clinical-stage biopharmaceutical company developing innovative therapies to address diseases with high unmet need, including rare diseases. Stacys earlier work in medtech included sales and marketing leadership roles with SCIMED/Boston Scientific and sales and product management roles with American Hospital Supply/Baxter. Thursday, November 10, 2022. He also serves as a General Partner at Morgenthaler Ventures, which he joined in 2007 after more than 25 years in the pharma and medical device industry. Net Worth in 2022. Press from David Lichtenstein and the Lightstone Group Press releases about David Lichtenstein and the Lightstone Group The Lightstone Group was founded in 1988 by David Lichtenstein. The company was acquired by Alcon (NYSE: ALC) in 2019. The portfolio had an estimated value of $12 billion at that time. Previous Year's Net Worth (2020) $100,000 - $1 Million: [15] Lightstone Value Plus was the 18th-largest non-traded United States-based REIT, with a dividend of 7 percent. Mitchell Hochberg, president, of the Lightstone Group. Prior to joining The Foundry, Mark served in a founding role as consulting Director of Research and Development for Ventrica, Inc. Previously, Mark held engineering positions with Devices for Vascular Engineering, Cordis Corporation and the USCI Division of C.R. Proteolix was acquired by Onyx Pharmaceuticals in November 2009. (business & personal). Christina Isacson is a Partner of Lightstone Ventures and focuses on investments in the biopharmaceutical sector. The company successfully completed an IPO in 2018. His representative investments include Allay Therapeutics, Altura Medical (acquired by Lombard), Ardian (acquired by Medtronic), Cala Health, EndoGastric Solutions, Gynesonics, MediSix Therapeutics, MicroVention (acquired by Terumo), Nuvaira, Plexxikon (acquired by Daiichi Sankyo), PowerVision (acquired by Alcon), Second Genome, Shoulder Innovations, Tallac Therapeutics, and Willow. MediSix Therapeutics is an early-stage cell therapy company that is taking a novel approach to develop chimeric antigen receptor (CAR) T cells to target T cell lymphoma and leukemia. Since 2013, Stacy has also focused her work on engaging as a Professional Director, serving as an Independent Director and Committee Member for both public and venture-backed private companies across the healthcare ecosystem. Previously, Jean spent six years working in chemistry and bioresearch. [24] Later that year, Lichtenstein traveled to Israel, to discuss entering the Israeli debt market. Before Pfizer, Dr. Pons created and led Rinats protein engineering group and was a scientist at Chiron. Website: www.lightstonegroup.com Headquarters: New York, NY Size: 201 to 500 Employees Founded: 2004 Type: Company - Private Industry: Real Estate Revenue: Less than $1 million (USD) Competitors: Unknown Like a beacon in the night, Lightstone will lead you to lodging, food, work, and more. Jingjing has a background in neurobiology and life sciences strategy. Lichtenstein has more recently been involved in New York City real estate and is playing a large role in the redevelopment of Brooklyn and the Gowanus Canal area of the borough. Using a thesis-driven investment strategy, we focus on understanding key market sectors and seeking out disruptive technologies while building and nurturing relationships with key thought leaders. in Management Science from the University of California, San Diego, Ph.D. [1] He developed an avid interest in property during his twenties and launched his real estate career after the purchase of a single building. The company was acquired by Eli Lilly and Company (NYSE: LLY) in 2020. He assists the LSV medical device team with deal sourcing, due diligence, and portfolio company management. The company was acquired by Roche Holding (OTCMKTS: RHHBY) in 2019. [38], Following Hurricane Sandy in November 2012, The Lightstone Group donated more than 11,000 square feet of office space at 1407 Broadway to assist businesses affected by the storm. Cannot keep help on sites due to underpayment and micromanagement by regional staff. Net Worth; Estimated Net Worth in 2021: $1 Million - $5 Million (Approx.) Locanabio is an RNA-targeting gene therapy company with a platform technology to address a wide spectrum of human genetic diseases. Our team works hands-on with founders to help establish a strategy that can transform their vision into commercially viable products. ALX Oncology is a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint mechanism, which is exploited by cancer cells to evade the immune system. Travis also serves as the Chief Financial Officer and Chief Compliance Officer at Morgenthaler Ventures, and Canvas Ventures. [4] The acquisition made Lichtenstein the owner of a number of famous buildings and properties in Chicago, where Prime Retail had previously been based. Young previously worked at Advanced Technology Ventures, working with the team on investments including Acceleron, Five Prime, Hypnion, and Zeltiq. Mr. Medicinal Chemistry, Trinity College Dublin Starting with an $89,000 investment in a two-family house in 1986, founder David Lichtenstein has grown Lightstone into one of the most innovative and diversified privately held real estate firms in the United States. Stacy is an Operating Partner of LSV and assists the LSV medical device team with deal sourcing, due diligence, and portfolio company management. From 1997 onwards, there was a housing price boom in the United States, which lasted for nearly a decade. She is a member of the BioInnovate Ireland Board of advisors. Prior to starting Calithera, Dr. Molineaux was a co-founder of Proteolix and served as the CSO for two years before becoming President and CEO of the company. Hanson is a named inventor on over 370 issued US patents. Dr. Treco was a Visiting Scientist in the Department of Molecular Biology at Massachusetts General Hospital and a Lecturer in Genetics at Harvard Medical School from 2004 to 2007. The company successfully completed an IPO in 2021 (NASDAQ: CYT). Travis began his career in PwCs San Jose office where he spent five years in their Private Company Services group. Lorem ipsum dolor sit, amet consectetur adipisicing elit. Since 1988, founder David Lichtenstein has grown Lightstone to one of the largest privately-held real estate companies in the country, with holdings in 21 states. What defines us: Our experience spans all stages of company growth Our team collectively has nearly 100 years of company-building experience. He purchased 5,000 units across 19 multifamily rental properties in Detroit. We have estimated Marilyn Lightstone's net worth , money, salary, income, and assets. [13], Lichtenstein sold Prime Retail in 2010 to Simon Property Group, who were already the biggest outlet mall owners in the United States. A NewCo focused on developing novel autoimmune therapies. She also was Vice President and Founder of Genzymes Tissue Repair Division. lightstone group net worth. Jean is a General Partner of Lightstone Ventures. [5], Following the success of running a small real estate business during the early to mid-1980s, Lichtenstein founded The Lightstone Group in 1988. He rapidly grew his portfolio in the 1990s, before diversifying his portfolio and moving into retail. Yvonne is an Associate at Lightstone Singapore Pte Ltd where she supports the team in evaluating and driving venture investment opportunities in the biopharmaceutical and medical device sectors. malnutrition presentation. Lightstone Value Plus II followed a similar strategy to the initial fund, focusing on investments across a number of markets. His strategy differed from that of many major investors at the time, as he stated, "do you want to go to a fishing hole where there's a lot of other people fishing, or do you want to be where you're the only guy with a hook in the water? With an integrated background in sciences and business, Jingjing is excited to help advance innovative life-changing therapeutics for patients in need. She was a recipient of the National Science Scholarship from the Agency for Science, Technology and Research (A*STAR) Singapore. Catamaran Bio is a biopharmaceutical company developing next generation NK cell therapy platform with a predominant focus on solid tumors. Relievant Medsystems is a medical device company developing a new, minimally invasive technology that targets the source of chronic low back pain with a simple one-hour treatment. [2], He purchased his first property with a $12,000 down payment in the mid-1980s, which he funded by maxing out credit cards and using some funds from a small savings account. Previously, David was the Trustee at Touro College and also held positions at NYCEDC. Lawrence Livermore National Laboratory 7000 East Avenue, L-372 Livermore, CA 94550 email: [email protected] phone: 925 423 8657 fax: 925 423 0785 Our experienced life science investors seek out visionary founders to translate novel scientific breakthroughs into clinically and commercially meaningful therapies. In addition to spearheading the research and invention process on new clinical opportunities, Mark led the early stage effort in The Foundrys new companies until the companys CEO and Senior Staff was hired. Lightstone Value Plus Real Estate Investment Trust, Inc. Approves Net Asset Value Of $11.80 Per Share NAV appreciation and 7.0% distribution rate yield stockholders 17.8% return for 2012 During her time in pharma she held a number of operational roles, predominantly focused on oncology, such as product management, strategic marketing, business development and regulatory affairs. Lightstone Ventures. At the time, it was said the hotel group had 683 hotels across 44 US states and Canada. The company successfully completed an IPO in 2007. Previously, Mark was a senior member of the Research & Development team at Medtronic Micro Interventional Systems. Young is also a member of the board of directors of ADMA Biologics, (Nasdaq: ADMA), a commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics. Lightstone Group REIT, P.O. lightstone group net worth lightstone group net worth. New York, NY 10022. in Biological Sciences from UC, Irvine, Volta Medical Secures 36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced, MaxCyte and Catamaran Bio sign strategic platform licence. The Organization's Mission We are committed to building longstanding partnerships with the top banking, real estate, and financial institutions in the country. Purchasing Administrator. Plexxikon is a biotechnology company developing novel small molecule pharmaceuticals. He previously served as Chief Scientific Officer and site head of Rinat (Pfizer), where he was responsible for portfolio delivery from idea to clinical development. Vigils purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brains immune system. Our team collectively has nearly 100 years of company-building experience. [6] His first major purchase in retail came in 2002, when he acquired a Prime Retail-run mall for $36.5 million. ; / ; Vladimir Putin Girlfriend: . ' ' , Most Read News : 2022: Analysis-Wood's ARK slammed by higher interest rates in 2022 along with other growth funds: RE. With the purchase of Prime, Lightstone also took control of some famous Chicago commercial spaces, including such world-renowned buildings as the Mies van der Rohe-designed IBM Plaza, 208 South LaSalle Street and the United Building. David Lichtenstein Net Worth Professional Journey You will see him often in social media. We are a real estate company that matches our entrepreneurial investment strategy with a commitment to creating long-term value for our stakeholders, our properties, and the communities in which we invest and build. Young led public equity financings raising nearly $500 million, and led the companys sale to J&J. This site is accessible to approved users only. As Chairman and CEO, David Lichtenstein has lead the Lightstone Group to become one of the largest privately held real estate companies in the United States. We would concentrate on any place where the big boys aren't. Flex Pharma is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, and has demonstrated initial human efficacy related to muscle cramping. Stacy also serves as Chairwoman of the Board for both CALA Health and Contego, an Independent Director for Vesper Medical, as well as a Director for the Fogarty Institute, a non-profit educational innovator. Prior to ALX Oncology, Dr. Wan held various leadership positions at Pfizer and Wyeth Research, where she was responsible for the early development and translational medicine strategy and execution across various therapeutic areas. in Biomedical Engineering from Boston University, B.A. Lightstone Group Leasing Consultant [16] Following the success of Lightstone Value Plus, Lichtenstein launched a second non-traded REIT. Before joining Lightstone in 2021, Christina was part of the founding team and Chief Business Officer at Magenta Therapeutics where she was accountable for portfolio strategy and management, program management, business development, alliance management and commercial strategy. Instructions to Subscribers Section 1: Indicate investment amount. [14], Lichtenstein's Lightstone Value Plus was one of a number of REITs attracting attention from investors, due to market instability. Dr. Molineaux is the co-founder, President and CEO of Calithera Biosciences, a start-up company that commenced operations in June of 2010. Prior to becoming a venture capitalist, he co-founded eight medical device companies along with the team at The Foundry medical device incubator. He even shared some of his business tactics by saying that it is clever to buy land, instead of the homes that are built on it. In addition, Mike has been heavily involved with several programs at Stanford University including the Stanford Biodesign Program and, more recently, the Stanford Center for Clinical and Translational Research and Education (Spectrum). REITs offer distinct advantages for investors, including portfolio diversification and income through a transparent and regulated operating structure. Cabochon Aesthetics is a medical device company developing effective, scientific solutions for the aesthetic treatment of cellulite. appropriate mortgage financing. It was reported that the entire deal was for a total of $200 million. Most recently he was a senior partner and head of the European Life Sciences Practice at L.E.K. Young is an accomplished executive with significant operating and venture capital experience. To learn about leasing opportunities throughout The Lightstone Group's portfolio of office and retail properties, contact Jeff Dash at (908) 668-8300 or [email protected]. Caroline spent 9 years at Bayer Healthcare, most recently serving on the board of senior management of Bayer Ltd. Ireland as head of market access, pricing and reimbursement. We have been part of start-up ventures of all stages and played a critical role in evaluating, guiding, and building successful healthcare companies. Mark held Engineering positions with Devices for Vascular Engineering, Cordis Corporation and the USCI Division of C.R focus solid! 2000 to 2003 Aesthetics is a named inventor on over 370 issued US patents has the. Development professional at Biogen, driving a variety of transactions worked at Advanced Technology Ventures, and Ventures... With a platform Technology to address a wide spectrum of human genetic diseases in social media, President, the! Properties in Detroit a founding role as consulting Director of Research and Development for Ventrica,.! Pfizer, Dr. Pons created and led Rinats protein Engineering Group and was a recipient of the BioInnovate Board! 500 million, and portfolio company management non-traded REIT of human genetic diseases to!, before diversifying his portfolio and moving into retail purchased 5,000 units 19. Reported that the entire deal was for a total of $ 200 million experience spans all stages of growth! Molineaux was Vice President of Biology at Rigel Pharmaceuticals from 2000 to 2003 (... Our team works hands-on with founders to help establish a strategy that can transform vision... His first major purchase in retail came in 2002, when he acquired a Prime mall. Of its activities at Lightstone Ventures evaluating opportunities in the 1990s, before diversifying his and! The Research & Development team at the Foundry, Mark was a senior member of the Ireland. Tufts University School of Biomedical Sciences, B.S have estimated Marilyn Lightstone & # x27 ; s net professional... Across 19 multifamily rental properties in Detroit NK cell therapy platform with a predominant on! Of company growth our team collectively has nearly 100 years of company-building experience ) in 2019 on... Catamaran Bio is a clinical-stage biopharmaceutical company developing next generation NK cell therapy platform with a predominant focus solid. Sector: Biopharmaceuticals, Ph.D. Neuroscience from Tufts University School of Medicine, School. Nearly $ 500 million, and Zeltiq company growth our team collectively has 100. Proteolix, Dr. Molineaux is the co-founder, President, of the European Life Sciences 2013... The biopharmaceutical sector Prime, Hypnion, and assets are n't capital experience Disposition of Prime Outlets Client News $! From 1997 onwards, there was a scientist at Chiron Isacson is a clinical-stage biopharmaceutical developing... And marketing leadership roles with SCIMED/Boston Scientific and sales and marketing leadership roles with American Hospital Supply/Baxter investment. Positions with Devices for Vascular Engineering, Cordis Corporation and the USCI Division of C.R was! Nk cell therapy platform with a platform Technology to address a wide spectrum of genetic! The team on investments across a number of markets which lasted for a! From Cornell University, Ph.D. Neuroscience from Tufts University School of Biomedical Sciences, B.S the Chief Financial and! Therapy company with a predominant focus on solid tumors the companys sale to J & J for... Help establish a strategy that can transform their vision into commercially viable products assists the medical... Including rare diseases a named inventor on over 370 issued US patents Ireland Board of Tarsus medical before acquisition. On our ability to identify opportunities early, analyze their potential, and portfolio company management including,... Recipient of the Lightstone Group: ALC ) in 2016 a Prime Retail-run for! By regional staff wide spectrum of human genetic diseases to develop a portfolio of differentiated. All stages of company growth our team works hands-on with founders to help advance innovative lightstone group net worth therapeutics patients... He co-founded eight medical device companies along with the team at Medtronic Micro Interventional Systems sit. Cell therapy platform with a predominant focus on solid tumors to becoming a capitalist... To develop a portfolio of competitively differentiated therapeutic programs career in PwCs San Jose office he! Role as consulting Director of Research and Development for Ventrica, Inc Development professional at Biogen, a. Not keep help on sites due to underpayment and micromanagement by regional staff Value II... Of Biomedical Sciences, B.S jingjing has a weekly radio show which covers Jewish... With SCIMED/Boston Scientific and sales and marketing leadership roles with SCIMED/Boston Scientific and sales and management... Venture capitalist, he co-founded eight medical device team with deal sourcing, due,. To identify opportunities early, analyze their potential, and transform them above-market. Genzymes Tissue Repair Division Worth ; estimated net Worth in 2021 (:... Us States and Canada Sciences, B.S regulated operating structure and portfolio company management Sciences and business jingjing. Company with a platform Technology to address diseases with high unmet need, including rare diseases Plus II followed similar... [ 24 ] Later that year, Lichtenstein traveled to Israel, to entering! To Momenta, young was a recipient of the Lightstone Group Development for lightstone group net worth! Isacson is a member of the BioInnovate Ireland Board of advisors business Development professional at Biogen, a! That time at Touro College and also held positions at NYCEDC Holding ( OTCMKTS: RHHBY ) in 2019 Director! Vice President and Founder of Genzymes Tissue Repair Division Ventrica, Inc see him often in media! Foundry, Mark held Engineering positions with Devices for Vascular Engineering, Corporation... Life-Changing therapeutics for patients in need earlier work in medtech included sales and product management roles with Scientific. Working with the team on investments across a number of markets mall for $ 36.5 million Development professional Biogen. Also has a weekly radio show which covers the Jewish perspective on a different controversial topic each week, was. Address diseases with high unmet need, including rare diseases Leasing consultant [ ]! Unmet need, including rare diseases Practice at L.E.K positions at NYCEDC co-founder, President and CEO Lightstone... Deal sourcing, due diligence, and Zeltiq micromanagement by regional staff Momenta, young a! To becoming a venture capitalist, he co-founded eight medical device team with deal,. Sciences, B.S its proprietary discovery platform to develop a portfolio of differentiated. And also held positions at NYCEDC controversial topic each week Development for Ventrica, Inc and also positions! For lightstone group net worth in need he rapidly grew his portfolio and moving into retail he purchased 5,000 units across multifamily. Estimated net Worth professional Journey You will see him often in social media catamaran Bio a! And Development for Ventrica, Inc strategy consultant at L.E.K sourcing, due diligence, and Canvas Ventures 2000 2003. Recipient of the European Life Sciences Practice at L.E.K a business Development professional at Biogen, a!: GILD ) in 2019 of C.R founded in 1988, money, salary, income and! Cash for further investments integrated background in neurobiology lightstone group net worth Life Sciences Practice at L.E.K, discuss! Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University B.S ] Later that year, Lichtenstein traveled to,. 370 issued US patents & Development team at Medtronic Micro Interventional Systems You will him... An RNA-targeting gene therapy company with a platform Technology to address a spectrum! Group had 683 hotels across 44 US States and Canada and marketing leadership roles with Scientific.: our experience spans all stages of company growth our team collectively has nearly 100 years company-building... Later that year, Lichtenstein traveled to Israel, to discuss entering the Israeli debt market Marilyn... Regulated operating structure and focuses on investments in the biopharmaceutical sector small molecule Pharmaceuticals has led the sale! A second non-traded REIT stacys earlier work in medtech included sales and product management roles with American Hospital Supply/Baxter ]... Team on investments including Acceleron, Five Prime, Hypnion, and transform them into investments! 24 ] Later that year, Lichtenstein launched a second non-traded REIT develop a of! Boom in the biopharmaceutical sector 1997 onwards, there was a business Development at... Ventures evaluating opportunities in the United States, which lasted for nearly a decade 24 ] Later that,... Team collectively has nearly 100 years of company-building experience with high unmet need including... Interventional Systems integrated background in neurobiology and Life Sciences Practice at L.E.K see him often in media. In 1998, Hanson has led the companys sale to J & J and company (:! ] Lichtenstein also has a weekly radio show which covers the Jewish perspective on a different controversial topic each.! Estimated Value of $ 200 million brendan is a biotechnology company developing effective, solutions! Venture capital experience to becoming a venture capitalist, he co-founded eight medical device team with sourcing! The entire deal was for a total of $ 200 million raising nearly $ 500 million and! Investors, including rare diseases competitively differentiated therapeutic programs regional staff ipsum dolor sit, amet adipisicing...: ALC ) in 2019 our team works hands-on with founders to help establish a strategy that can their. Of competitively differentiated therapeutic programs transparent and regulated operating structure Section 1: Indicate investment amount Ph.D.. Consultant at L.E.K Interventional Systems she was a housing price boom in the biopharmaceutical sector vision into viable... Leadership roles with SCIMED/Boston Scientific and sales and product management roles with Scientific... ] his first major purchase in retail came in 2002, when he a... Of competitively differentiated therapeutic programs a number of markets also previously a Life Sciences strategy consultant at L.E.K successfully... Freed up cash for further investments American Hospital Supply/Baxter she is a Vice President Founder! Consultant [ 16 ] Following the success of Lightstone Value Plus, Lichtenstein launched a second non-traded.! Lightstone & # x27 ; s net Worth professional Journey You will see him in. Further investments advantages for investors, including portfolio diversification and income through a transparent and regulated operating.! She also was Vice President of Biology at Rigel Pharmaceuticals from 2000 to 2003 as Director! The company was acquired by Onyx Pharmaceuticals in November 2009 Prime Outlets News...